AIC
ABBV icon

Aurora Investment Counsel’s AbbVie ABBV Stock Holding History

Aurora Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,623
Closed -$425K – 119
2022
Q1 		$425K Sell
2,623
-8,637
-77% -$1.25M 0.27% 115
2021
Q4 		$1.52M Buy
11,260
+1,945
+21% +$230K 0.91% 46
2021
Q3 		$1M Sell
9,315
-45
-0.5% -$5.14K 0.7% 79
2021
Q2 		$1.05M Buy
9,360
+34
+0.4% +$3.83K 0.74% 72
2021
Q1 		$1.01M Sell
9,326
-188
-2% -$20.1K 0.74% 75
2020
Q4 		$1.02M Buy
9,514
+31
+0.3% +$2.98K 0.82% 62
2020
Q3 		$941K Buy
9,483
+98
+1% +$9.23K 0.77% 70
2020
Q2 		$921K Buy
+9,385
New +$826K 0.87% 55

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aurora Investment Counsel's ABBV Position: Q2 2022 in Review

Aurora Investment Counsel sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 2,623 shares — an estimated $425K sold.

Aurora Investment Counsel first reported a position in ABBV in Q2 2020 and held it in 8 quarters. The position peaked at $1.52M in Q4 2021. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Aurora Investment Counsel reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Aurora Investment Counsel sold 2,623 AbbVie shares in Q2 2022, an estimated $425K.
  • Aurora Investment Counsel first reported a position in AbbVie in Q2 2020 and held it in 8 quarters.
  • Aurora Investment Counsel's AbbVie position peaked at $1.52M in Q4 2021.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Aurora Investment Counsel's 13F filing for Q2 2022, filed 12 Aug 2022.